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The world’s political, engineering, and
scientific communities are gathered
at the United Nations head offices for
a three-day meeting to celebrate the
conquering of two of humanity’s great-
est scourges: climate change and the
scarcity of potable water.
In today’s sessions, the assembled
masses are paying homage to the role
the Human Genome Project and its
progeny played in these historic ac-
complishments. In retrospect, it is inter-
esting tonote that thisproject, launched
to sequence the human genome, would
have by far its greatest impact on hu-
man health by enabling the discovery,
characterization, and engineering of
proteins and organisms that had not
yet even been discovered or imagined
when the project was launched near
the turn of the millennium.
The speakers chose to highlight two
major bioengineering achievements.
Thefirstwas thedevelopmentof thecar-
bon-fixing biofactories that now dot the
globe. The influence of the microbial
world on geochemical cycles was
known at the time, but it could not have
been imagined that scientists would
manage to integrate their knowledge of
systems metabolism, protein structure,
and enzymology to engineer the car-
bon-fixing microbes that are now being
used to regulate atmospheric carbon.
That these microbes are being used to
fuel today’s bioengine solar cars is an
equally significant accomplishment.
The second achievement that is
being celebrated is the development
of home sewage treatment processes
that provide recycled potable water
on the household and village level.
This development, which was enabled
by the creation of highly efficient biore-
actors harboring batteries of engi-
neered catabolic pathways, was hailedas the bioengineering discovery that
has saved the most lives in human his-
tory. It not only reduced water-borne
disease by 94%, but also all but elimi-
nated the threat of world conflict over
water. Interestingly, 78% of the cata-
bolic pathways that are integrated
into most home treatment systems
incorporate enzymes that were not
discovered until after 2015, and 15%
of the enzymes were designed from
scratch based on the fundamental
knowledge of protein and enzyme
structure and function.
The keynote speaker, a structural
biologist and enzymologist, took time
to reflect on the course of genome-
based science that led to these ac-
complishments.
She related that the late 1980s and
early 1990s, the Human Genome Pro-
ject was launched with much hope,
but also with much skepticism, and
even outright antagonism. Why focus
on finding new genes when there
were so many ‘‘important’’ old ones
to study? Of course the tide of opinion
had turned in the early 2000s and sci-
entists from most disciplines began to
come to terms with the new genome
reality: the reality in which the size of
the global ‘‘metagenome,’’ comprising
all the mysterious ORFs in bacteria, ar-
chaea, and viruses, dwarfed even the
most adventurous predictions. Appre-
ciating how profoundly the microbes
in the biosphere influence human
health, scientists began to study the
mystery genes and proteins in the in-
habitants of our bodies, the soil, and
the oceans. Amusingly, it was in fact
these studies, not those focused on
predefined ‘‘important problems’’ in
biomedicine nor what was gleaned
from the human genome, that led to
the two achievements we celebrate
today.Structure 15, December 2007 ª2She then chose to focus on one of
these projects, the NIH-funded Protein
Structure Initiative (PSI), which has
a storied history and whose supporters
in 2000 would be amazed at its seminal
influence. The PSI was launched in the
United States with the aim to predict
the structure and function of all newly
discovered proteins. The first phase
focused on developing experimental
methodologies to provide data that
linked sequence and structure. In
2005, the effort took stock of the ex-
panding number of sequences and rea-
soned that a more systematic mapping
of the protein universe was warranted.
In 2008, as the structures of represen-
tatives of large and small protein fami-
lies were churning out, an interesting
phenomenon occurred. The effort,
which had focused solely on structural
biology, appreciated that it had also de-
veloped the capacity to purify proteins
at a rate previously unimaginable. The
PSI then began to work hand-in-hand
with the genome sequencing centers
to create large-scale experimental ‘‘gene
to function’’ annotation centers. The
combined gene/protein centers devel-
oped ‘‘Grand Challenges’’ of enzymol-
ogy and systematically scoured the
genetic universe for enzymes of imme-
diate and long-term societal impor-
tance, and developed the long-term
goal of creating new enzymes.
The first direct success of the PSI-
Genome collaboration occurred in
2014, when experimental scientists dis-
covered and characterized unbelievably
versatile and plastic enzymes from bac-
teria that inhabited the seabed under
the oceans off Nunavut. Their computa-
tional colleagues found that the en-
zymes provided excellent scaffolds
that could be modified to create ‘‘en-
zymes on demand.’’ These newly cre-
ated enzymes found practical utility first007 Elsevier Ltd All rights reserved 1525
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remediation, and finally in the personal
sewage treatment systems of today.
In 2023, the PSI-Genome Centers
were already designing organisms har-
boring proteins with exquisitely tuned
metabolic pathways. Organisms were
engineered with proteins designed to
operate in any environment and built-
in mechanisms to inhibit the spread of
their genes to naturally occurring spe-
cies. The ‘‘organisms and pathways
on demand’’ methods ultimately led to
the development of dual use carbon-
fixing microbes that are being used to
reduce atmospheric CO2 and to fuel
the new solar biocars that we all drive
today.
And here we are in 2030, in one of
the most optimistic times of human
history. Indeed even Toronto Maple
Leaf and Chicago Cubs fans are hope-
ful, certain that this will be the year they
finally win a championship.
Toronto. October 18, 2007
OK, so this is optimistic fantasy (or
maybe not). But the fact remains that
all the research on the ‘‘important’’
well-defined problems in biomedicineSome Ill Conside
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The PSI must be considered from
three perspectives: (1) its impact on
science, (2) its policy implications,
and (3) its effects on funding structural
biology. In terms of its scientific im-
pact, I have some deep concerns,
chiefly related to the objectives and
the focus of the program, which
have, it appears to me, not been con-
sistent and clear. Initially, PSI had, I
vaguely recall, the stated purpose of
solving the structures comprising the
1526 Structure 15, December 2007 ª200have had less impact on human health
than have, for example, the poorly
characterized microbial communities
in sewage treatment plants. Similarly,
the microbes that live in our soil and
oceans, through their effects on the
planet’s climate and the elemental cy-
cles, are more central to our existence
than any medical treatment. If impact
on human health is a metric of impor-
tance, it is clearly important to study
problems outside what currently ap-
pears tobedirectly ‘‘relevant’’ to human
disease.
But therein lies the rub. We need to
understand the biome, or metage-
nome, but the questions are difficult
to define. How should one approach
such an ill-defined problem?
No one really knows, and this doubt-
less contributes to the angst about
funding structural and functional stud-
ies of the metagenome. And nowhere
is this angst felt more strongly than in
the structural biology community; the
holistic approach to science that
defines metagenomics is not in any
structural biologist’s ‘‘comfort zone.’’
Indeed, perhaps more than any other
branch of biomedical research, struc-red Comments o
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human proteome. Swiftly abandoning
that too ambitious idea, PSI was then
going to fill protein folding space with
carefully selected (by bioinformatics
miracles) gene products. This all
proved too demanding, so various or-
ganisms were chosen by different PSI
centers, and everyone started off in
all directions. Then some centers
dropped the idea entirely of solving
proteomes of anything and focused
on proteins that might serve the needs
7 Elsevier Ltd All rights reservedtural biology revels in precision and
accuracy and absolutism.
Yet the area is among the most im-
portant in modern science. So how
should structural biochemists get in-
volved? The genome sequencing and
annotation communities know full
well. There is a pressing need for ex-
perimental, protein-based annotation
of the new genes. Much as the won-
drous intricacies of DNA replication
and RNA transcription were revealed
through the efforts of structure-based
biochemistry and enzymology, uncov-
ering the innumerable mysteries of the
metagenome depend on similar ap-
proaches, only on a larger and more
integrated scale. All scientists, includ-
ing biochemists, enzymologists, and
structural biologists need to get with
the program.
Where to start? Again, it is impossi-
ble to say, but in our view the current
PSI aim to better define the protein
universe at a structural level is a good
first step. The natural next step for
the PSI is to forge closer links with
the genome sequencing centers in
a concerted effort to link sequence to
structure to function.n the
ine, CA 92697, USA
of drug designers and pharmaceutical
development. Some turned to address
specific classes of enzymes, while
others continued to churn out what-
ever it was that crystallized. Any co-
herent theme vanished, and to this ob-
server, it has yet to be found again or
reconstructed. A major problem with
the current PSI is that its objectives
have become so scrambled that co-
herence has disappeared from the
program. Perhaps my vision is simply
